There were several studies have described the increased levels of circulating soluble E-selectin in patients with diabetes, obesity, and coronary artery disease, and soluble VCAM-1 and/or soluble ICAM-1 are increased in patients with metabolic syndrome who involve both male and female [18–23]. Here, SELE is linked to metabolic syndrome.